All Articles

Editorial Commentary 
Quality assurance in thoracic oncology: the surgeon’s perspective
Paraskevas Lyberis, Federico Femia, Enrico Ruffini
Precision Cancer Medicine  
2023;
6:
20  
Case Report 
Locally advanced HPV-positive oropharyngeal cancer cured with single agent pembrolizumab in a patient using cannabis: a case report
Azamat Abdyraimov, Nikita Karpovich, Lesia Tkachuk, Karine Darbinyan
Precision Cancer Medicine  
2023;
6:
19  
Case Report 
A challenge in emergency department: a case report of oxaliplatin-induced Kounis syndrome
Marcello Albanesi, Raffaele Didonna, Nada Chaoul, Federica Mazzone, Marco Zurlo, Fortunato Iacovelli, Francesco Monitillo, Flavio Rimmaudo, Marco Tucci, Mauro Cives, Camillo Porta, Vito Procacci
Precision Cancer Medicine  
2023;
6:
18  
Editorial 
A quality assurance program: a clear necessity in modern oncology care
Paul Van Houtte, Dirk Van Gestel
Precision Cancer Medicine  
2023;
6:
12  
Case Report 
Endoscopic endonasal removal of nasal cavity chondrosarcoma extending to the base of the skull: a case report
Nikita I. Mikhailov, Anton M. Zaitsev, Andrew G. Rerberg, Sergei A. Kisarev, Gennadei I. Khokhrikov, Artem E. Lazarev, Olga N. Kirsanova, Tatyana M. Kobyletskaya, Tatiana S. Bezbabicheva, Angelina V. Krivobokova, Peter V. Shegay, Andrey D. Kaprin
Precision Cancer Medicine  
2023;
6:
9  
Review Article 
Radiotherapy in non-surgical management of esophageal cancer in the era of immuno-oncology: a narrative review
Hongcheng Zhu, Jingyi Shen, Mohamed Emam Sobeih, Xinmin Zhao, Huijun Zhu, Kuaile Zhao
Precision Cancer Medicine  
2023;
6:
8  
Review Article 
The use of 18F-FDG PET/CT for radiotherapy treatment planning in non-small cell lung cancer: a mini-review
Eleni Gkika, Anca L. Grosu, Ursula Nestle
Precision Cancer Medicine  
2023;
6:
7  
Review Article 
Emerging drivers in non-small cell lung cancer, is there a role for immunotherapy?—a narrative review
Leonardo Brunetti, Valentina Santo, Marco Russano, Alessio Cortellini, Alessandro Galletti, Fabrizio Citarella, Giuseppina-Rita Di Fazio, Alessia Vendittelli, Giulia La Cava, Bruno Vincenzi, Giuseppe Tonini, Daniele Santini
Precision Cancer Medicine  
2023;
6:
6  
Review Article 
Lung cancer surgery in women: focus on gender-related outcomes—a narrative review
Carmelina C. Zirafa, Gaetano Romano, Elisa Sicolo, Andrea Castaldi, Federico Davini, Franca Melfi
Precision Cancer Medicine  
2023;
6:
5  
Review Article 
Favouring quality improvement initiatives: the experience of the Belgian College of Radiation Oncology
Aude Vaandering, Sarah Roels, Burak Yalvaç, Nathalie Reulens, Brigitte Reniers, Frederik Vanhoutte, Vincent Remouchamps, Yolande Lievens, Reinhilde Weytjens
Precision Cancer Medicine  
2023;
6:
4  
Original Article 
First-line ALK inhibitors in treatment-naive advanced ALK rearranged non-small cell lung cancer: systematic review and network meta-analysis
Aaron C. Tan, Sze Huey Tan, Mei-Kim Ang, Daniel S. W. Tan
Precision Cancer Medicine  
2023;
6:
3  
Editorial 
Biomarkers for immunotherapy in non-small cell lung cancer: a current and future reality
Alejandro Olivares-Hernández, José Pablo Miramontes-González, Juan Luis García Hernández, Edel del Barco Morillo, Emilio Fonseca-Sánchez
Precision Cancer Medicine  
2023;
6:
2  
Editorial 
Utility of intraparenchymal blood patch testing following CT-guided lung biopsy
Khezar Syed, Bryan S. Benn, Jonathan S. Kurman
Precision Cancer Medicine  
2023;
6:
1  
Case Report 
Gonadotropin releasing hormone agonist-related meningioma progression causing abducens nerve palsy: an oncological case report
Michael J. McKay, Ritwik Pandey, Hassan Zadeh, Kim Taubman
Precision Cancer Medicine  
2022;
5:
40  
Review Article 
Immune microenvironment and immunotherapy in pancreatic cancer: a narrative review
Xiaoning Yu, Si Shi, Xianjun Yu
Precision Cancer Medicine  
2022;
5:
39  
Review Article 
Applications of generative adversarial networks (GANs) in radiotherapy: narrative review
Zhixiang Wang, Glauco Lorenzut, Zhen Zhang, Andre Dekker, Alberto Traverso
Precision Cancer Medicine  
2022;
5:
37  
Study Protocol 
Protocol: screening of genetic susceptibility genes for breast cancer patients and establishment of genetic high-risk populations cohort in east china communities
Zezhou Wang, Sanjian Yu, Xiaoshuang Feng, Xia Qiu, Hui Ji, Hailin Shan, Qing Shao, Heng Xia, Feng Cao, Jun Li, Cuixia Fu, Liqin Chen, Xiaofang Lu, Tingting Su, Qianqian Yu, Shengqun Hou, Honglian Wang, Yun Liu, Ying Zheng, Zhimin Shao, Zhen Hu
Precision Cancer Medicine  
2022;
5:
36  
Original Article 
Cancer incidence and mortality in Shanghai: rates in 2016 and trends from 2002 to 2016
Chunxiao Wu, Kai Gu, Yi Pang, Pingping Bao, Chunfang Wang, Liang Shi, Yangming Gong, Yongmei Xiang, Jianming Dou, Mengyin Wu, Yan Shi, Chen Fu
Precision Cancer Medicine  
2022;
5:
35  
Expert Consensus 
Chinese expert consensus recommendations for management of bone health in female patients with early breast cancer (2022 edition)
The Society of Breast Cancer of China Anti-Cancer Association, Breast Cancer Study Group Along Yangtze River
Precision Cancer Medicine  
2022;
5:
33  
Editorial 
Introduction to Management of Triple Negative Breast Cancer
Jacques Raphael
Precision Cancer Medicine  
2022;
5:
32  
Editorial 
Neuroimaging aspects and clinical significance of giant perivascular spaces in the brain
Giuseppe Barisano
Precision Cancer Medicine  
2022;
5:
31  
Editorial Commentary 
Uncommon EGFR mutations in non-small-cell lung cancer
Marco Russano, Giuseppe Perrone, Giuseppina Rita Di Fazio, Alessandro Galletti, Fabrizio Citarella, Valentina Santo, Leonardo Brunetti, Alessia Vendittelli, Bruno Vincenzi, Giuseppe Tonini, Daniele Santini
Precision Cancer Medicine  
2022;
5:
30  
Case Report 
Giant perivascular spaces in brain: case report with a comprehensive literature review
Gaurav Cheraya, Suryansh Bajaj, Salil Sharma, Darshan Gandhi, Jignesh Shah, Nisarg Parikh, Nishant Gupta
Precision Cancer Medicine  
2022;
5:
29  
Review Article 
Moving through rare lung cancer histologies: a narrative review on diagnosis and treatment of selected infrequent entities
Chiara Pisano, Gianluca Witel, Marco De Filippis, Angela Listì, Francesca Napoli, Luisella Righi, Silvia Novello, Paolo Bironzo
Precision Cancer Medicine  
2022;
5:
27  
Review Article 
Review: biological implications of oncogenic rearrangements in non-small cell lung cancer
Maria Vittoria Di Marco, Claudia Voena
Precision Cancer Medicine  
2022;
5:
26  
Review Article 
Current state of the art on the diagnosis and the role of target therapy for treatment of ROS1-rearranged non-small cell lung cancer: a narrative review
Francesca Parisi, Giovanni Rossi, Federica Biello, Marco Tagliamento, Giulia Barletta, Lodovica Zullo, Eugenia Cella, Gianluca Sacco, Chiara Dellepiane, Elisa Bennicelli, Diletta Favero, Angela Alama, Simona Coco, Silvia Marconi, Linda Zinoli, Enrica Teresa Tanda, Paolo Pronzato, Erika Rijavec, Carlo Genova
Precision Cancer Medicine  
2022;
5:
25  
Review Article 
Clinical implications of liquid biopsies in urogenital tumors: a narrative review
Laudy Chehade, Ali H. Abdel Sater, Hampig Raphael Kourie, Deborah Mukherji, Ali Shamseddine
Precision Cancer Medicine  
2022;
5:
24  
Review Article 
A narrative review of epidemiology and prevention of lung cancer: sex/gender differences?
Sandra Baldacci, Sara Maio, Claudia Meschi, Davide Chimera, Sofia Tagliaferro, Anna Antonietta Angino, Patrizia Silvi, Francesco Pistelli, Laura Carrozzi
Precision Cancer Medicine  
2022;
5:
23  
Editorial 
Lung cancer in women
Editta Baldini
Precision Cancer Medicine  
2022;
5:
22  
Editorial 
How should clinicians manage metastatic non-small cell lung cancer patients with BRAF non-V600E mutations?
Edyta Maria Urbanska
Precision Cancer Medicine  
2022;
5:
21  
Case Report 
RET-mutated non-small cell lung cancer treated with pralsetinib: a case series
Alessandro Galletti, Marco Russano, Fabrizio Citarella, Giuseppina Di Fazio, Valentina Santo, Leonardo Brunetti, Bruno Vincenzi, Giuseppe Tonini, Daniele Santini
Precision Cancer Medicine  
2022;
5:
20  
Case Report 
Ineffective target therapy in non-small cell lung cancer harboring BRAF G466R mutation: a case report and biological rationale
Fabrizio Citarella, Marco Russano, Giuseppe Perrone, Giuseppina-Rita Di Fazio, Raffaele Giusti, Bruno Vincenzi, Giuseppe Tonini, Daniele Santini
Precision Cancer Medicine  
2022;
5:
19  
Case Report 
KRAS G12V mutation as an acquired resistance mechanism after treatment with dabrafenib and trametinib in non-small cell lung cancer harbouring the BRAF V600E mutation: a case report
Hajime Oi, Kiyotaka Yoh, Shingo Matsumoto, Hiroki Izumi, Yuji Shibata, Tetsuya Sakai, Kaname Nosaki, Yoshitaka Zenke, Koichi Goto
Precision Cancer Medicine  
2022;
5:
18  
Review Article 
Current evidence of BRCA mutations in genitourinary and gynecologic tumors: a scoping review
Alain Chebly, Tony Yammine, Elie Rassy, Stergios Boussios, Michele Moschetta, Chantal Farra
Precision Cancer Medicine  
2022;
5:
17  
Review Article 
The role of digital and integrative pathology for the detection of translocations: a narrative review
Carlo Beretta, Stefano Ceola, Fabio Pagni, Vincenzo L’Imperio
Precision Cancer Medicine  
2022;
5:
16  
Review Article 
Drug-related toxicity in breast cancer patients: a new path towards tailored treatment?—a narrative review
Eleonora Lai, Mara Persano, Marco Dubois, Dario Spanu, Clelia Donisi, Marta Pozzari, Giulia Deias, Giorgio Saba, Marco Migliari, Nicole Liscia, Mariele Dessì, Mario Scartozzi, Francesco Atzori
Precision Cancer Medicine  
2022;
5:
15  
Review Article 
The past, present, and future of non-metastatic castration-resistant prostate cancer (nmCRPC): a narrative review
Natalia Vidal, Juan Gómez Rivas, Laura Fernández, Jesús Moreno, Javier Puente
Precision Cancer Medicine  
2022;
5:
14  
Review Article 
A narrative review of the management of BRAF non-V600E mutated metastatic non-small cell lung cancer
Inas Abuali, Chung-Shien Lee, Nagashree Seetharamu
Precision Cancer Medicine  
2022;
5:
13  
Original Article 
Prospective and single-blinded evaluation of the multi-cancer Carcimun-test
Andreas Salat, Wieland Voigt, Berthold von und zu Zwerger
Precision Cancer Medicine  
2022;
5:
12  
Editorial 
From icing to slicing the cake: the new hope of precision medicine for lung cancer
Giuseppe L. Banna, Alfredo Addeo
Precision Cancer Medicine  
2022;
5:
11